Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for PRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -305.24M
March 31, 2026 -282.41M
December 31, 2025 -249.07M
September 30, 2025 -228.77M
June 30, 2025 -191.24M
March 31, 2025 -163.88M
December 31, 2024 -131.76M
September 30, 2024 -98.40M
June 30, 2024 -94.15M
March 31, 2024 -98.11M
December 31, 2023 -110.13M
September 30, 2023 -115.10M
Date Value
June 30, 2023 -136.84M
March 31, 2023 -162.76M
December 31, 2022 -184.23M
September 30, 2022 -200.32M
June 30, 2022 -179.40M
March 31, 2022 -152.34M
December 31, 2021 -123.79M
September 30, 2021 -99.18M
June 30, 2021 -89.12M
March 31, 2021 -69.06M
December 31, 2020 -51.93M
September 30, 2020 -41.67M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Heron Therapeutics, Inc. -11.61M
Insmed, Inc. -778.92M
Ionis Pharmaceuticals, Inc. -496.43M
Perspective Therapeutics, Inc. -93.07M
Regeneron Pharmaceuticals, Inc. 4.681B